235 related articles for article (PubMed ID: 23154545)
1. G-protein coupled receptor family C, group 5, member A (GPRC5A) expression is decreased in the adjacent field and normal bronchial epithelia of patients with chronic obstructive pulmonary disease and non-small-cell lung cancer.
Fujimoto J; Kadara H; Garcia MM; Kabbout M; Behrens C; Liu DD; Lee JJ; Solis LM; Kim ES; Kalhor N; Moran C; Sharafkhaneh A; Lotan R; Wistuba II
J Thorac Oncol; 2012 Dec; 7(12):1747-1754. PubMed ID: 23154545
[TBL] [Abstract][Full Text] [Related]
2. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
[TBL] [Abstract][Full Text] [Related]
3. Knockout of the tumor suppressor gene Gprc5a in mice leads to NF-kappaB activation in airway epithelium and promotes lung inflammation and tumorigenesis.
Deng J; Fujimoto J; Ye XF; Men TY; Van Pelt CS; Chen YL; Lin XF; Kadara H; Tao Q; Lotan D; Lotan R
Cancer Prev Res (Phila); 2010 Apr; 3(4):424-37. PubMed ID: 20354164
[TBL] [Abstract][Full Text] [Related]
4. A Gprc5a tumor suppressor loss of expression signature is conserved, prevalent, and associated with survival in human lung adenocarcinomas.
Kadara H; Fujimoto J; Men T; Ye X; Lotan D; Lee JS; Lotan R
Neoplasia; 2010 Jun; 12(6):499-505. PubMed ID: 20563252
[TBL] [Abstract][Full Text] [Related]
5. Modulation of cystatin A expression in human airway epithelium related to genotype, smoking, COPD, and lung cancer.
Butler MW; Fukui T; Salit J; Shaykhiev R; Mezey JG; Hackett NR; Crystal RG
Cancer Res; 2011 Apr; 71(7):2572-81. PubMed ID: 21325429
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of chronic obstructive pulmonary disease-related non-small cell lung cancer through aberrant methylation and alterations of EGFR signaling.
Suzuki M; Wada H; Yoshino M; Tian L; Shigematsu H; Suzuki H; Alaa M; Tamura H; Fujiwara T; Nagato K; Motohashi S; Moriya Y; Hoshino H; Yoshida S; Shibuya K; Hiroshima K; Nakatani Y; Yoshino I
Ann Surg Oncol; 2010 Mar; 17(3):878-88. PubMed ID: 19841986
[TBL] [Abstract][Full Text] [Related]
7. Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer.
Micke P; Mattsson JS; Edlund K; Lohr M; Jirström K; Berglund A; Botling J; Rahnenfuehrer J; Marincevic M; Pontén F; Ekman S; Hengstler J; Wöll S; Sahin U; Türeci O
Int J Cancer; 2014 Nov; 135(9):2206-14. PubMed ID: 24710653
[TBL] [Abstract][Full Text] [Related]
8. EGFR phosphorylates and inhibits lung tumor suppressor GPRC5A in lung cancer.
Lin X; Zhong S; Ye X; Liao Y; Yao F; Yang X; Sun B; Zhang J; Li Q; Gao Y; Wang Y; Liu J; Han B; Chin YE; Zhou BP; Deng J
Mol Cancer; 2014 Oct; 13():233. PubMed ID: 25311788
[TBL] [Abstract][Full Text] [Related]
9. Genomic Landscape Established by Allelic Imbalance in the Cancerization Field of a Normal Appearing Airway.
Jakubek Y; Lang W; Vattathil S; Garcia M; Xu L; Huang L; Yoo SY; Shen L; Lu W; Chow CW; Weber Z; Davies G; Huang J; Behrens C; Kalhor N; Moran C; Fujimoto J; Mehran R; El-Zein R; Swisher SG; Wang J; Fowler J; Spira AE; Ehli EA; Wistuba II; Scheet P; Kadara H
Cancer Res; 2016 Jul; 76(13):3676-83. PubMed ID: 27216194
[TBL] [Abstract][Full Text] [Related]
10. High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and EGFR [corrected] mutation.
Nunez MI; Behrens C; Woods DM; Lin H; Suraokar M; Kadara H; Hofstetter W; Kalhor N; Lee JJ; Franklin W; Stewart DJ; Wistuba II
J Thorac Oncol; 2012 May; 7(5):833-40. PubMed ID: 22729036
[TBL] [Abstract][Full Text] [Related]
11. Gprc5a deletion enhances the transformed phenotype in normal and malignant lung epithelial cells by eliciting persistent Stat3 signaling induced by autocrine leukemia inhibitory factor.
Chen Y; Deng J; Fujimoto J; Kadara H; Men T; Lotan D; Lotan R
Cancer Res; 2010 Nov; 70(21):8917-26. PubMed ID: 20959490
[TBL] [Abstract][Full Text] [Related]
12. Augmented Lipocalin-2 Is Associated with Chronic Obstructive Pulmonary Disease and Counteracts Lung Adenocarcinoma Development.
Treekitkarnmongkol W; Hassane M; Sinjab A; Chang K; Hara K; Rahal Z; Zhang J; Lu W; Sivakumar S; McDowell TL; Kantrowitz J; Zhou J; Lang W; Xu L; Ochieng JK; Nunomura-Nakamura S; Deng S; Behrens C; Raso MG; Fukuoka J; Reuben A; Ostrin EJ; Parra E; Solis LM; Spira AE; McAllister F; Cascone T; Wistuba II; Moghaddam SJ; Scheet PA; Fujimoto J; Kadara H
Am J Respir Crit Care Med; 2021 Jan; 203(1):90-101. PubMed ID: 32730093
[No Abstract] [Full Text] [Related]
13. GPRC5a suppresses the proliferation of non-small cell lung cancer under wild type p53 background.
Er J; Chao L; Yiwei L; Feng X; Fei Z; Kan W; Ruifei X
Exp Lung Res; 2020 Sep; 46(7):226-233. PubMed ID: 32410473
[No Abstract] [Full Text] [Related]
14. Enhancement of lung tumorigenesis in a Gprc5a Knockout mouse by chronic extrinsic airway inflammation.
Barta P; Van Pelt C; Men T; Dickey BF; Lotan R; Moghaddam SJ
Mol Cancer; 2012 Jan; 11():4. PubMed ID: 22239913
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical overexpression of platelet-derived growth factor receptor-beta (PDGFR-β) is associated with PDGFRB gene copy number gain in sarcomatoid non-small-cell lung cancer.
Tsao AS; Wei W; Kuhn E; Spencer L; Solis LM; Suraokar M; Lee JJ; Hong WK; Wistuba II
Clin Lung Cancer; 2011 Nov; 12(6):369-74. PubMed ID: 21729646
[TBL] [Abstract][Full Text] [Related]
16. Transcriptomic architecture of the adjacent airway field cancerization in non-small cell lung cancer.
Kadara H; Fujimoto J; Yoo SY; Maki Y; Gower AC; Kabbout M; Garcia MM; Chow CW; Chu Z; Mendoza G; Shen L; Kalhor N; Hong WK; Moran C; Wang J; Spira A; Coombes KR; Wistuba II
J Natl Cancer Inst; 2014 Mar; 106(3):dju004. PubMed ID: 24563515
[TBL] [Abstract][Full Text] [Related]
17. p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue.
Lo Iacono M; Monica V; Saviozzi S; Ceppi P; Bracco E; Papotti M; Scagliotti GV
J Thorac Oncol; 2011 Mar; 6(3):473-81. PubMed ID: 21289519
[TBL] [Abstract][Full Text] [Related]
18. Development of Kras mutant lung adenocarcinoma in mice with knockout of the airway lineage-specific gene Gprc5a.
Fujimoto J; Nunomura-Nakamura S; Liu Y; Lang W; McDowell T; Jakubek Y; Ezzeddine D; Kapere Ochieng J; Petersen J; Davies G; Fukuoka J; Wistuba II; Ehli E; Fowler J; Scheet P; Kadara H
Int J Cancer; 2017 Oct; 141(8):1589-1599. PubMed ID: 28653505
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC).
Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR
Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526
[TBL] [Abstract][Full Text] [Related]
20. Stat3 downstream genes serve as biomarkers in human lung carcinomas and chronic obstructive pulmonary disease.
Qu P; Roberts J; Li Y; Albrecht M; Cummings OW; Eble JN; Du H; Yan C
Lung Cancer; 2009 Mar; 63(3):341-7. PubMed ID: 18614255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
